Impact of Baroreflex Activation Therapy on Renal Function - A Pilot Study | Zendy

Manuel Wallbach | Zendy; Luca-Yves Lehnig | Zendy; Charlotte Schroer | Zendy; Gerd Hasenfuß | Zendy; Gerhard A. Müller | Zendy; Rolf Wachter | Zendy; Michael Koziolek | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Baroreflex Activation Therapy on Renal Function - A Pilot Study

Author(s) -

Manuel Wallbach,

Luca-Yves Lehnig,

Charlotte Schroer,

Gerd Hasenfuß,

Gerhard A. Müller,

Rolf Wachter,

Michael Koziolek

Publication year - 2014

Publication title -

american journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 85

eISSN - 1421-9670

pISSN - 0250-8095

DOI - 10.1159/000368723

Subject(s) - medicine , renal function , albuminuria , urology , cystatin c , kidney disease , creatinine , endocrinology , blood pressure , proteinuria , baroreflex , excretion , kidney , heart rate

Resistant hypertension and chronic kidney disease (CKD) are interlinked via sympathetic overdrive. Baroreflex activation therapy (BAT) has been shown to chronically reduce blood pressure (BP) in patients with resistant hypertension. The effect of BAT on renal function in CKD patients with resistant hypertension has not been reported. The aim of this study was to investigate the effect of sympathetic inhibition on renal function in CKD patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research